Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation-Reference-Cited by-同舟云学术

Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation

Published:2014-11-19 Issue:2 Volume:90 Page:144-148
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Hamilton Betty K.¹,Rybicki Lisa²,Dean Robert¹,Majhail Navneet S.¹,Haddad Housam³,Abounader Donna¹,Hanna Rabi⁴,Sobecks Ronald¹,Duong Hien¹,Hill Brian T.¹,Copelan Edward⁵,Bolwell Brian¹,Kalaycio Matt¹

Affiliation:

1. Blood & Marrow Transplant Program; Department of Hematologic Oncology and Blood Disorders; Cleveland Clinic Taussig Cancer Institute; Cleveland Ohio

2. Quantitative Health Sciences; Cleveland Clinic Lerner Research Institute; Cleveland Ohio

3. Hematology/Oncology; Staten Island University Hospital; New York New York

4. Pediatric Hematology Oncology; Cleveland Clinic; Cleveland Ohio

5. Levine Cancer Institute; Carolinas HealthCare System; Charlotte North Carolina

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23882/fullpdf

Reference42 articles.

1. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: An analysis of clinical risk features and outcome;Weisdorf;Blood,1990

2. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors;Nash;Blood,2000

3. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation;Ratanatharathorn;Blood,1998

4. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia;Storb;N Engl J Med,1986

5. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF);Allison;Clin Transplant,1996

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation;The Lancet Haematology;2024-02

2. Cancer Therapy–Related Hypertension: A Scientific Statement From the American Heart Association;Hypertension;2023-03

3. Acute Graft-Versus-Host Disease;Basics of Hematopoietic Stem Cell Transplant;2023

4. Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation;Leukemia & Lymphoma;2022-02-10

5. Combination of Low-Dose, Short-Course Mycophenolate Mofetil With Cyclosporine and Methotrexate for Graft-Versus-Host Disease Prophylaxis in Allogeneic Stem Cell Transplant;Experimental and Clinical Transplantation;2021-12